Paul Landsman
About Paul Landsman
Paul Landsman is a Scientist, Analytical CMC at Bristol-Myers Squibb with extensive experience in pharmaceutical product development and analytical technologies.
Current Role at Bristol-Myers Squibb
Paul Landsman currently serves as Scientist, Analytical CMC at Bristol-Myers Squibb in Devens, MA. In this role, he is involved in designing and executing stability, compatibility, and in-use studies for pharmaceutical products. He leverages his experience with Design of Experiments (DOE) and Quality by Design (QbD) approaches to contribute to product and process development. His responsibilities also include authoring reports and Standard Operating Procedures (SOPs) in compliance with regulatory guidelines.
Previous Employment History
Before joining Bristol-Myers Squibb, Paul Landsman amassed diverse experience across multiple organizations. He spent 9 months at GreenLight Biosciences, Inc. as a Scientist – Platform Development in Medford, MA. Prior to that, he worked for two years at Charles River Laboratories as a Senior Scientist in Shrewsbury, MA. He also served as a Scientist in Technology Investment at Biogen for five years in Cambridge, MA. His earlier roles include a one-year stint as a Staff Scientist at Formatech, Inc. and a brief tenure of 9 months as a Scientist at NIBR.
Academic Background and Postdoctoral Research
Paul Landsman earned his Doctor of Philosophy (Ph.D.) in Chemistry and Biochemistry from the Weizmann Institute of Science, where he studied from 1990 to 1996. Before that, he achieved a Master’s Degree in Chemistry from Moscow State University, completing his studies there from 1978 to 1982. His postdoctoral research experience includes spending six years at Boston University and five years at the University of Bar-Ilan in Ramat Gan, Israel.
Expertise in Pharmaceutical Development
Paul Landsman brings extensive expertise in the pharmaceutical industry, particularly in stability, compatibility, and in-use studies for pharmaceutical products. He utilizes rigorous methodologies like Design of Experiments (DOE) and Quality by Design (QbD). His experience spans evaluating and developing new analytical technologies, managing cross-functional projects, and authoring regulatory-compliant reports. His work is grounded in strong adherence to GMP/ICH guidelines and compliance with GxP environments.
Project Management and CRO Evaluation
Throughout his career, Paul Landsman has successfully managed and led multiple cross-functional projects and investigational studies. He has significant experience in working with Contract Research Organizations (CROs) and vendors, having evaluated CROs and managed outsourced projects. His role frequently involves technology evaluation studies, ensuring that the latest analytical technologies and platforms are effectively implemented and transferred.